Trials / Completed
CompletedNCT02760342
A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Metformin
ASP015K Pharmacokinetic Study: Evaluation of Drug-Drug Interaction Between ASP015K and Metformin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the pharmacokinetic interactions between ASP015K and metformin in healthy non-elderly male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | peficitinib | Oral |
| DRUG | Metformin | Oral |
Timeline
- Start date
- 2016-05-15
- Primary completion
- 2016-06-26
- Completion
- 2016-06-26
- First posted
- 2016-05-03
- Last updated
- 2024-10-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02760342. Inclusion in this directory is not an endorsement.